Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

757.18 +2.83 (+0.38%)
Official Closing Price Updated: 7:00 PM EDT, Apr 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,458,147
Open 755.57
Bid (Size) 750.00 (2)
Ask (Size) 760.00 (2)
Prev. Close 754.35
Today's Range 751.49 - 765.31
52wk Range 677.09 - 972.53
Shares Outstanding N/A
Dividend Yield 0.69%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Skye Bioscience's Obesity Candidate Shows 30% Weight Loss When Combined With Eli Lilly's Blockbuster Drug In Animal Models
Skye shares surge after new data shows nimacimab reduces weight over 30% with tirzepatide, with stable potency and promising obesity treatment potential. 
Via Benzinga
Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch
Mounjaro's launch in India sparks a surge in patient demand as Eli Lilly gains a market edge ahead of Novo Nordisk and upcoming generic competition. 
Via Benzinga

Performance

YTD
-2.7%
-2.7%
1 Month
-8.2%
-8.2%
3 Month
-5.1%
-5.1%
6 Month
-18.5%
-18.5%
1 Year
+0.9%
+0.9%

More News

Read More
Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?
Via The Motley Fool
Verve Therapeutics Touts Positive Data From Gene Editing Medicine To Lower Cholesterol After Single Dose
Via Benzinga
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
Via The Motley Fool
What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?
Via Benzinga
Eli Lilly Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
Pfizer Ends Development Of Weight Loss Pill Due To Potential Drug-Induced Liver Injury In A Patient
Via Stocktwits
Topics Government
Exposures Political
Pfizer Scraps Obesity Pill After Potential Drug-Tied Liver Injury
Via Investor's Business Daily
Investing $60,000 in These 3 Funds Could Generate Annual Income of Over $6,500
Via The Motley Fool
Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties
Via Benzinga
3 Value Stocks in the Doghouse
Via StockStory
Building Wealth Through Economics: A Patriotic Investor’s Guide To Tariffs 2.0 And Why
Via Talk Markets
Topics ETFs Stocks / Equities World Trade
Exposures Tariff
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
China Deal Is 'Going To Work Out,' Trump Says As Stocks Bounce From Session Lows
Via Benzinga
Topics Government
Exposures Political
Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy Government World Trade
Exposures Economy Political Tariff
Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.
Via Investor's Business Daily
Topics Government
Exposures Political Product Safety
Behind the Scenes of Eli Lilly's Latest Options Trends
Via Benzinga
Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device
Via Investor's Business Daily
Topics Government Stocks World Trade
Exposures Political Product Safety Tariff
Hims’ Weight Loss Expansion: Real Growth or Just Hype?
Via MarketBeat
Exposures Product Safety
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
Via Benzinga
Topics Government Supply Chain World Trade
Exposures Political Supply Chain Tariff
What's going on in today's session: S&P500 movers
Via Chartmill
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
Via The Motley Fool
Topics Government World Trade
Exposures Political Tariff
Eli Lilly CEO David Ricks Just Delivered Terrible News to Investors: Should You Sell the Stock?
Via The Motley Fool
Topics Economy Government World Trade
Exposures Economy Political Tariff

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 757.18
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 04/15/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.